chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Baby given vaccines and then put in infant carrier. Became quiet, still and pale. Aroused within seconds and crying, moving legs and arms, pulse strong and regular. EMS called (911). Color improved and fine rash noted on legs and abdomen (flat and light colored). EMS stated acute reaction. Mother and father took immediately to pediatrician. Had another episode on the way to doctor and sent to ER and admitted to hospital. 3/25/05 Client discharged after 24 hour admission and testing. Referred to pediatrician for follow up. Follow-up: 8/24/05-TC to mother who states child is doing well and she has continued visits to the Pediatrician. They plan to resume vaccine when pt is 9 mon-1 yr of age and will probably "space them" rather than receiving at one time. At this time the parents just want to wait". Baby is healthy otherwise. 12/31/09 (9/21/06) Mother states child is to receive vaccine at private MD office at spaced intervals rather than simultaneously and "is nearly caught up for her age." Dr. had diagnosed incident as a vasovagal response-but no further symptoms as inital situation has occurred.
I received my fifth dose of my Moderna vaccine at the same time as receiving my flu shot. I had the soreness that I always have, but suddenly the injection site on my left arm got really red and swollen and hot and then it spread down to the top of my elbow and up toward my armpit and my left breast. I was in a lot of pain for a few days. I had a telehealth appointment where my doctor indicated that I either had an infection from the person not cleaning the area properly or a reaction to the vaccine. He put me on prednisone and Cephalexin on 09/09/2022. From 09/09/2022 to 09/11/2022 I noticed during that time that my blood pressure would get high, and thing were worse when I laid down. There were two nights where I would wake up and when I got up, I was in a lot of pain. As of today, my swelling has gone away, and I have a bit of tenderness but only in the localized area of the injection and it is very light.
Chills, muscle pain, injection site pain, nausea, felt unwell, arm pain and decreased appetite. Treatment included rest. After 15 hours symptoms went away.
Patient reports that he received the vaccine in his left shoulder, instead of his left deltoid.  This has left him in considerable pain for the past week.  He has consulted his physician who is currently monitoring the patient.
This spontaneous report was received from a physician via company representatives and refers to a patient of unknown age and gender. The patient's medical history, concurrent conditions or concomitant therapies were not reported. On 09-SEP-2015, the patient was vaccinated orally with a dose of 2 ml of ROTATEQ 10 unit dose tube, lot # K000487, expiration date 27-SEP-2015. This vaccine was improperly stored exposed to four temperature excursions, one for a sum of 24 hours with a lowest temperature recorded as -1 degree C; other for a sum of 48 hours with a lowest temperature recorded as 0 degree C; another for a sum of 48 hours with a lowest temperature recorded as 1 degree C, and the last one for a sum of 72 hours with a highest temperature recorded as 9 degree C. The vaccine status was reported as "in excursion". The vaccine storage criteria and type were reported as "refrigerator (R)". No adverse effects were reported. There was no product quality complain involved. This is one of several reports received from the same reporter. Additional information has been requested.
Doses were stored in the freezer before administration; doses administered past expiration; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (doses administered past expiration) and PRODUCT STORAGE ERROR (Doses were stored in the freezer before administration) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 048C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 26-Nov-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 26-Nov-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (doses administered past expiration). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Doses were stored in the freezer before administration). At the time of the report, EXPIRED PRODUCT ADMINISTERED (doses administered past expiration) and PRODUCT STORAGE ERROR (Doses were stored in the freezer before administration) outcome was unknown.  For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. No concomitant medication was provided. Doses were stored in the freezer before administration. One dose was administered on 26-Nov-2021  No treatment information was provided.
First episode Feb 18 (16 days after first Covid vaccine): fainting, shortness of breath at onset of light exercise (called Dr., advised to drink more water). Second episode: Feb. 23, one day after second Covid-19 shot: inflamed left calf, redness of skin.  Dr. and ER visit Feb. 24, diagnosed with critical DVT and  multiple pulmonary embolisms.  ER put me on heparin IV drip, Overnight stay in hospital, discharged with Eliquis blood thinner prescription.  Continuing  that med for life, per hematologist
Headache, Myalgia, NauseaVomiting, Pain in arm, chills Narrative:
My shoulders began hurting. I could not flex my left arm for a couple of days. That was now over 2 months ago, and I still have pain and stiffness, in both shoulders, that I never had before the vaccination.
This spontaneous report as received from a pharmacy technician concerning a currently 10 years old child. Gender was not reported. Medical history and concurrent conditions were not reported. On 15-APR-2014, the patient was vaccinated with VARIVAX (Merck) lot #J009165; expiration date: 24-JUL-2015, (dose, strength and route were not reported). Secondary and concomitant therapies were not reported. Patient was vaccinated with VARIVAX (Merck) that was exposed to 43.1 degrees F for 29 hours on 03-MAR-2014. This is one of several reports from the same reporter. Additional information has been requested.
Blister on arm at injection site and 3 blisters on right side which took a couple of weeks to heal.  Then on August 15 starting having vision problems in right eye which continued to worsen.  Visited ophthalmologist on August 20 and 21. Eye scan and field vision tests done.  Vision continued to worsen and was referred to emergency room on August 24 by ophthalmologist.  Brain scan and brain MRI done in ER.  Referred to neurologist appointment on August 26.  Admitted to hospital that day. Orbitz MRI, lumbar puncture and numerous blood and vision tests conducted.  Received high dose steroid infusions for 2 days in hospital and 3 days at home.  Referred to neuro-ophthalmologist appointment on September 15. Referred to retina specialist appointment on October 21 for a multifocal electroretinagram.  Retina specialist confirmed permanent retina damage caused by vaccine attacking eye.
"swollen lymph node under arm pit." (injection site arm); Pain in arm.( injection site arm); This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE LYMPHADENOPATHY ("swollen lymph node under arm pit." (injection site arm)) and VACCINATION SITE PAIN (Pain in arm.( injection site arm)) in a 55-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE LYMPHADENOPATHY ("swollen lymph node under arm pit." (injection site arm)) and VACCINATION SITE PAIN (Pain in arm.( injection site arm)). At the time of the report, VACCINATION SITE LYMPHADENOPATHY ("swollen lymph node under arm pit." (injection site arm)) and VACCINATION SITE PAIN (Pain in arm.( injection site arm)) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant product use was not provided by the reporter. Treatment information was not provided.    This case was linked to MOD21-076254, US-MODERNATX, INC.-MOD-2021-077735, US-MODERNATX, INC.-MOD-2021-077745, US-MODERNATX, INC.-MOD-2021-077965 (E2B Linked Report).; Sender's Comments:  MOD21-076254: US-MODERNATX, INC.-MOD-2021-077735: US-MODERNATX, INC.-MOD-2021-077745: US-MODERNATX, INC.-MOD-2021-077965:
No Adverse Reaction from patient, but the patient did receive an incorrect DOSE during the series. He received the ENGERIX-B Ped dose. Correction was made and completed on 1/10/2018 with Adult ENGERIX-B.
Jynneos vaccine was drawn up into the syringe 35 minutes before it was administrated to the patient.; Jynneos vaccine was drawn up into the syringe 35 minutes before it was administrated to the patient.; Case reference number US-BN-2022-002247 is a spontaneous case report initially received on 01-Sep-2022 from a pharmacist (reference number: USBAV22-1249), and concerns a patient of unknown age and gender.  The patient's medical history and concomitant medication details were not reported.  On an unspecified date, the patient received Jynneos vaccine (Smallpox and Monkeypox Vaccine, Live, Nonreplicating; batch number: unknown) that was drawn up into the syringe 35 minutes before the administration at an unknown dose, route, or site of administration, for smallpox/ monkeypox (explicitly coded as ' Product storage error', 'Product administration error ').  At the time of this report, it was unknown which dose this was, or whether the patient experienced any adverse events due to Jynneos.  Additional information received on 05-Sep-2022 from Bavarian Nordic included local case ID.  This case is linked with US-BN-2022-002245 and US-BN-2022-002246 concerning the same reporter; Reporter's Comments: A patient of unknown age and gender received the Jynneos vaccine that was drawn up into the syringe 35 minutes before the administration, at an unknown dose, route, or site of administration, for smallpox/monkeypox, which is considered as product storage error and product administration error. At this point, it was unknown which dose this was, or whether the patient experienced any adverse events due to Jynneos. Product storage error and product administration error are both considered listed per company. The patient's medical history and concomitant medication details were not reported. Product storage error and product administration error are not related to Jynneos, but to a human factor. The case is non-serious.; Sender's Comments: A patient of unknown age and gender received the Jynneos vaccine that was drawn up into the syringe 35 minutes before the administration, at an unknown dose, route, or site of administration, for smallpox/monkeypox, which is considered as product storage error and product administration error. At this point, it was unknown which dose this was, or whether the patient experienced any adverse events due to Jynneos. Product storage error and product administration error are both considered listed per company. The patient's medical history and concomitant medication details were not reported. Product storage error and product administration error are not related to Jynneos, but to a human factor. The case is non-serious.
around 0900 pt reported feeling light headed and was diaphoretic. pt appeared pale. given water. vs taken. temp 98.9 PO, heart rate 69-76, RR 18-22, 02 sat 98%. after about 10 minutes and 2 bottles of water pt felt better, color resumed to normal. pt asked to wait the full 30 minutes.
The client was given the incorrect dose of pfizer vaccine for his age. He is 11 yrs old and recieved a 12 and up dose. This was the client's first dose. His mother was notified while they were here at the clinic. No adverse reactions were noted during the 15 min. Observation and client left in care of mom.
Around 48hrs later from my 2nd dose I started having chest pain in the middle of the night. I then developed a cough it was starting to worsen within the next 4-6 weeks. I started to have shortness of breath as well. I went to the doctor they said I had fluid surrounding my heart and lungs. I was hospitalized for about 4 days. I had a cardiac infection and heart failure. I now had to get therapy to straighten my heart.
Vial was initially stored in the refrigerator on 04 Apr 2022, expired on 01 Apr 2022 and administered on 16 Apr 2022; Expired vaccine administered to 155 patients; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Expired vaccine administered to 155 patients) and PRODUCT STORAGE ERROR (Vial was initially stored in the refrigerator on 04 Apr 2022, expired on 01 Apr 2022 and administered on 16 Apr 2022) in a 70-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026L21B) for COVID-19 vaccination.     No Medical History information was reported.    On 16-Apr-2022, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .25 milliliter. On 16-Apr-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Expired vaccine administered to 155 patients). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Vial was initially stored in the refrigerator on 04 Apr 2022, expired on 01 Apr 2022 and administered on 16 Apr 2022). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Expired vaccine administered to 155 patients) and PRODUCT STORAGE ERROR (Vial was initially stored in the refrigerator on 04 Apr 2022, expired on 01 Apr 2022 and administered on 16 Apr 2022) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications information was reported.  It was reported that the vial was stored in the refrigerator on 04-APR-2022. The vial did not undergo any temperature excursion. The pharmacist thought that the vaccine expire on Jun 2022, however it expired on 01 Apr 2022.   No treatment medications information was reported.   This case was linked to MOD-2022-551714 (Patient Link).
ONCE I GOT THE SECOND SHOT I HAD FACIAL CONGESTION, THEN MY EYES GOT BAGS UNDER THEM, I WAS HOARSE, MY FACE SWELLED, I HAD NASAL/EAR/SINUS CONGESTION, SOB, AND SEVERE JOINT PAIN STARTED. I HAD TO TAKE A STEROID TO BREATHE. THEN I BEGAN WITH ITCHING AND SEVERE MIGRAINES ON THE DAY I DID NOT TAKE THE STEROID. I AM STILL SUFFERING A MONTH LATER FROM THE JOINT PAIN, FATIGUE, SOB, HOARSENESS, FACIAL SWELLING/CONGESTION, DARK CIRCLES UNDER MY EYES, SEVERE JOINT PAIN-  I SAW THE ALLERGIST WHO GAVE ME MEDROL, XYZAL, AND XCHANCE- I HAD ADVERSE REACTION TO THE XYZAL-DIZZINESS AND FACE SWELLED AND I COULD NOT KEEP MY EYES OPEN OR STAND UP.  SO NOW I JUST TAKE MEDROL 4MG DAILY SO I DONT HAVE  ITCHING ALL OVER MY FACE/MIGRAINE/HOARSENESS./SEVERE JOINT PAIN. THE MEDROL JUST MAKES THE SYMPTOMS LESS. THE FATIGUE IS KILLING ME AND IM SO TIRED OF THE SYMPTOMS. MY STOMACH HURTS NOW TOO. I STARTED TAKING ZANTAC WITH CLARITIN FOR DOUBLE ANTIHISTAMINE EFFECT. MY MD DID LABS AND I GO BACK TO HIM.
I had severe fatigue, mild cough, and low grade fever. I tested positive for COVID-19 and called my doctor. She prescribed me Paxlovid and it made me feel worse. I still have fatigue.
HIGH BLOOD PRESSURE; DIZZINESS; This spontaneous report received from a patient concerned a patient of unspecified age and sex. The patient's height, and weight were not reported. The patient's concurrent conditions included hypertension. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1802072 expiry: UNKNOWN) dose was not reported, administered on 06-MAR-2021 for prophylactic vaccination. No concomitant medications were reported. On 06-MAR-2021, the subject experienced dizziness. On 08-MAR-2021, the subject experienced high blood pressure. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from dizziness, and high blood pressure. This report was non-serious.; Sender's Comments: V0: Medical assessment comment not required as per standard procedure as case assessed as non-serious.
On 01-07-2021, I tested positive to Covid. I had a very mild runny nose, stuffy nose and hands feel cool to touch. My oxygen Stats are stable.   My son had covid exposure  from his employer and he did not get treated.  My son and wife did not believe in Covid. I wore a mask throughout my home and sanitized all my areas.
did not report adverse event but the inflammation could be suspected as an Potential Adverse event; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of INFLAMMATION (did not report adverse event but the inflammation could be suspected as an Potential Adverse event) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 27-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 28-Jan-2021, the patient experienced INFLAMMATION (did not report adverse event but the inflammation could be suspected as an Potential Adverse event). The patient was treated with METHYLPREDNISOLONE (MEDROL [METHYLPREDNISOLONE]) for Inflammation, at an unspecified dose and frequency. At the time of the report, INFLAMMATION (did not report adverse event but the inflammation could be suspected as an Potential Adverse event) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.       No relevant concomitant medications were reported. inflammation was a potential suspected adverse event since Medrol was prescribed for inflammation.
Difficulty breathing/hyperventilating pain in neck and upper back/pain in lymph nodes - within 3 hrs of vaccination.
Fever 101 10/8/09 during night followed by vomiting early AM 10/9/09; vomiting every hour. Also with nasal congestion, runny nose, sore throat and headache. Vomiting, running nose, fever, headache, congestion during doctors visit. Sunday 10/11- rash all over body and strep throat and fever.
approx 14 hours after the injection (the next morning) there was mild soreness at the injection site and I had a mild headache approx 26 hours after the injection I became very tired and my eyes felt irritated. I felt like I was sick but not sick. It's hard to explain but it's like I felt the symptoms but it wasn't as bad as really being sick.
little more soreness than the first dose; two days of fatigue; This spontaneous case was reported by a consumer and describes the occurrence of MYALGIA (little more soreness than the first dose) and FATIGUE (two days of fatigue) in a 64-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included HIV infection NOS, Chronic pancreatitis and Blood pressure management.   In February 2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In March 2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced MYALGIA (little more soreness than the first dose) and FATIGUE (two days of fatigue). At the time of the report, MYALGIA (little more soreness than the first dose) outcome was unknown and FATIGUE (two days of fatigue) had resolved.            Concomitant drug included HIV Medication, Blood thinner medication, Chronic pancreatitis medication and blood pressure medication. Treatment medication was not reported. its mentioned in the report that patient has taken the 3RD dose of vaccine on 2nd sept 2021 Consumer mentioned that he had soreness in the injection site and fatigue. He said his arm is slightly swollen   This case was linked to MOD-2021-308626.   Most recent FOLLOW-UP information incorporated above includes: On 07-Sep-2021: Initiative Followup received.
first left my arm sore for most of a week... The second did the same; also got a slight rash; This non-serious case was reported by a consumer via interactive digital media and described the occurrence of pain in arm in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   Previously administered products included shingles vaccine with an associated reaction of pain in extremity (on an unknown date received 1st dose. for tolerance refer US2023AMR092401.).   On an unknown date, the patient received the 2nd dose of Shingles vaccine (left arm). On an unknown date, an unknown time after receiving Shingles vaccine, the patient experienced pain in arm (Verbatim: first left my arm sore for most of a week... The second did the same) and rash (Verbatim: also got a slight rash). Rechallenge with Shingles vaccine was positive. The outcome of the pain in arm and rash were not reported.   It was unknown if the reporter considered the pain in arm and rash to be related to Shingles vaccine.     It was unknown if the company considered the pain in arm and rash to be related to Shingles vaccine.   Linked case(s) involving the same patient:  US2023AMR092401   Additional Information: Additional Information: GSK Receipt Date: 01-Jul-2023 This case was reported by a patient via interactive digital media. The patient got two shots for shingles. The first left his/her arm sore for most of a week. The second did the same but the patient also got a slight rash. The patient had to not scratch it because it reacted badly.  The patient stated that get the shot, just the preview was enough to convince him/her.; Sender's Comments:  US-GSK-US2023AMR092401:Case for first  dose US-GSK-US2023AMR092401:Case for second dose
Information has been received from a medical assistant concerning a 20 year old patient, whom their 13 year old sibling on approximately 22-SEP-2010, six weeks ago, was vaccinated with a dose of VARIVAX (Merck) (Lot # not reported). Concomitant therapy included VALTREX. Medical assistant reported that the patient (13 year old's sibling) had developed shingles. The patient was diagnosed on 02-NOV-2010. The medical assistant did not report any adverse effect to the 13 year old patient who was vaccinated with VARIVAX (Merck) (Lot # not reported). The patient sought unspecified medical attention. At the time of the report the outcome of the patient was unknown. Additional information has been requested.
On 13MAY91, pt rec'd DPT # 4, warm, tender area 1 1/4 x 1 1/4 in rt lat thigh noted about 1 day later; Recovered in 2 days;
Red rash on arm, looks like sunburn but specifically around the injection site about 2" diameter. Slight pain when pressure applied. It's been a couple days since it showed and is starting to fade and become less painful.
shortness of breath; This spontaneous case was reported by a consumer and describes the occurrence of DYSPNOEA (shortness of breath) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced DYSPNOEA (shortness of breath). At the time of the report, DYSPNOEA (shortness of breath) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were provided by the reporter.  No treatment information was provided by the reporter.    Reporter did not allow further contact
Tired/lethargic since time of injection. Progressed to flu-like symptoms on evening of 3/19/2021. Intense back pain, body aches, nausea, vomiting, sweating and chills, very tired but unable to sleep. Tylenol has helped some. Had a brief (few minutes) episode of bad chest pain/pressure on morning of 3/20/2021, made it hard to breathe. No fever, cough, or sore throat.